Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.

    Maeshima AM, Tsuta K, Asamura H, Tsuda H.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27424. [Epub ahead of print]

    PMID:
    22282325
    [PubMed - as supplied by publisher]
    2.

    Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer.

    Camidge DR, Theodoro M, Maxson DA, Skokan M, O'Brien T, Lu X, Doebele RC, Barón AE, Varella-Garcia M.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27411. [Epub ahead of print]

    PMID:
    22282074
    [PubMed - as supplied by publisher]
    3.

    Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.

    Doebele RC, Lu X, Sumey C, Maxson DA, Weickhardt AJ, Oton AB, Bunn PA Jr, Barón AE, Franklin WA, Aisner DL, Varella-Garcia M, Camidge DR.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27409. [Epub ahead of print]

    PMID:
    22282022
    [PubMed - as supplied by publisher]
    4.

    Lung cancer with translocation in the anaplastic lymphoma kinase gene: A disease within a disease.

    Ramalingam SS, Khuri FR.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27402. [Epub ahead of print] No abstract available.

    PMID:
    22281941
    [PubMed - as supplied by publisher]
    5.

    Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer.

    Kapadia NS, Mamet R, Zornosa C, Niland JC, D'Amico TA, Hayman JA.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27401. [Epub ahead of print]

    PMID:
    22252390
    [PubMed - as supplied by publisher]
    6.

    Celecoxib may prevent lung cancer.

    Printz C.

    Cancer. 2012 Jan 1;118(1):3. doi: 10.1002/cncr.27371. No abstract available.

    PMID:
    22222881
    [PubMed - indexed for MEDLINE]
    7.

    A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.

    Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC.

    Cancer. 2011 Dec 5. doi: 10.1002/cncr.26667. [Epub ahead of print]

    PMID:
    22144047
    [PubMed - as supplied by publisher]
    8.

    Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.

    Lee JK, Park HS, Kim DW, Kulig K, Kim TM, Lee SH, Jeon YK, Chung DH, Heo DS, Kim WH, Bang YJ.

    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26668. [Epub ahead of print]

    PMID:
    22086654
    [PubMed - as supplied by publisher]
    9.

    Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

    Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ.

    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26628. [Epub ahead of print]

    PMID:
    22072536
    [PubMed - as supplied by publisher]
    10.

    Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy.

    Zhao X, Wang X, Wu W, Gao Z, Wu J, Garfield DH, Wang H, Wang J, Qian J, Li H, Jin L, Li Q, Han B, Lu D, Bai C.

    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26669. [Epub ahead of print]

    PMID:
    22072145
    [PubMed - as supplied by publisher]
    11.

    Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis.

    Simon GR, Schell MJ, Begum M, Kim J, Chiappori A, Haura E, Antonia S, Bepler G.

    Cancer. 2012 May 1;118(9):2525-31. doi: 10.1002/cncr.26522. Epub 2011 Oct 25.

    PMID:
    22028294
    [PubMed - in process]
    12.

    Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.

    Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA.

    Cancer. 2011 Oct 1;117(19):4381-9. doi: 10.1002/cncr.26029. Epub 2011 Mar 15.

    PMID:
    21412758
    [PubMed - indexed for MEDLINE]
    13.

    Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study.

    Joerger M, Burgers SA, Baas P, Smit EF, Haitjema TJ, Bard MP, Doodeman VD, Smits PH, Vincent A, Huitema AD, Beijnen JH, Schellens JH.

    Cancer. 2012 May 1;118(9):2466-75. doi: 10.1002/cncr.26562. Epub 2011 Sep 28.

    PMID:
    22031394
    [PubMed - in process]
    14.

    Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.

    Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY.

    Cancer. 2012 May 1;118(9):2454-65. doi: 10.1002/cncr.26492. Epub 2011 Sep 22.

    PMID:
    21952750
    [PubMed - in process]
    15.

    Predicting the need for palliative thoracic radiation after first-line chemotherapy for advanced nonsmall cell lung carcinoma.

    Higginson DS, Chen RC, Morris DE, Halle J, Rosenman JG, Socinski MA, Marks LB.

    Cancer. 2012 May 15;118(10):2744-51. doi: 10.1002/cncr.26495. Epub 2011 Sep 20.

    PMID:
    21935913
    [PubMed - in process]
    16.

    Clinicopathological features of lung adenocarcinoma with KRAS mutations.

    Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I.

    Cancer. 2011 Sep 15;117(18):4257-66. doi: 10.1002/cncr.26010. Epub 2011 Mar 8.

    PMID:
    21387273
    [PubMed - indexed for MEDLINE]
    17.

    Racial and regional disparities in lung cancer incidence.

    Underwood JM, Townsend JS, Tai E, Davis SP, Stewart SL, White A, Momin B, Fairley TL.

    Cancer. 2012 Apr 1;118(7):1910-8. doi: 10.1002/cncr.26479. Epub 2011 Sep 14.

    PMID:
    21918961
    [PubMed - indexed for MEDLINE]
    18.

    Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.

    Salgia R.

    Cancer. 2011 Sep 1;117(17):3889-99. doi: 10.1002/cncr.25935. Epub 2011 Feb 24. Review.

    PMID:
    21858799
    [PubMed - indexed for MEDLINE]
    19.

    Functional regulatory variants of MCL1 contribute to enhanced promoter activity and reduced risk of lung cancer in nonsmokers: implications for context-dependent phenotype of an antiapoptotic and antiproliferative gene in solid tumor.

    Jiang Y, Wang W, Wang J, Lu Y, Chen Y, Jin L, Lin D, He F, Wang H.

    Cancer. 2012 Apr 15;118(8):2085-95. doi: 10.1002/cncr.26502. Epub 2011 Sep 1.

    PMID:
    21887682
    [PubMed - indexed for MEDLINE]
    20.

    A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers.

    Kim DH, Park SE, Kim M, Ji YI, Kang MY, Jung EH, Ko E, Kim Y, Kim S, Shim YM, Park J.

    Cancer. 2011 Sep 1;117(17):4080-91. doi: 10.1002/cncr.25930. Epub 2011 Feb 24.

    PMID:
    21858804
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk